Wael Saber

9PUBLICATIONS
72CO-AUTHORS
Haematological tumoursRespiratory diseasesCardiovascular medicine and haematology not elsewhere classifiedGene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

Jakob Wirbel, Wael Saber, Michael J Martens

|Jan 23, 2026
Novel Genomic Biomarkers Improve Post-Hematopoietic Cell Transplantation Relapse Risk Stratification for Patients With Myelodysplastic Syndromes.

Tao Zhang, Paul L Auer, Jing Dong

|Oct 02, 2025
Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.

Christopher Strouse, Mark Juckett, Brent R Logan

|Jan 03, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.

Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki

|Feb 10, 2024
Donor germ-line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes.

Paul L Auer, Manzur Farazi, Tao Zhang

|Jan 23, 2024
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102.

Wael Saber, Aasthaa Bansal, Lily Li

Pageof 2

Frequent Collaborators

5 joint publications

Michael J Martens

3 joint publications

Corey Cutler

3 joint publications

Mary M Horowitz

3 joint publications

Asmita Mishra